P
ENDRED SYNDROME is a genetic disorder associated with profound sensorineural hearing loss and goiter (1) (2) (3) (4) . Affected individuals typically have structural anomalies of the inner ear: Mondini malformation (5-7), dilated vestibular aqueducts (8 -10) , and, in some cases, vestibular dysfunction (7) . The goiter in Pendred syndrome is variable in its expression. When present, it is multinodular and develops around puberty. Pendred syndrome is almost always associated with a positive perchlorate discharge test, whereby iodide is inappropriately discharged from the thyroid upon stimulation with perchlorate (or thiocyanate) (2, 3) . This suggests that the underlying defect affects the transport of iodide across the apical membrane or the incorporation of iodide into thyroglobulin (TG; i.e. an organification defect). In addition, patients often have high serum TG levels.
In 1997, the Pendred syndrome gene (PDS) was identified by a positional cloning strategy (11) . The approximately 5-kb PDS transcript shows striking tissue-specific expression, being highly expressed in human thyroid and expressed at much lower amounts in adult and fetal kidney as demonstrated by Northern analysis. RNA in situ hybridization studies have recently shown that the gene is also expressed within highly delimited regions of the mouse inner ear (12) .
The predicted protein (pendrin) contains 780 amino acids (predicted to be 86 kDa) and is a member of a large family of anion transporters (13) . Pendrin's closest mammalian relatives include the proteins encoded by CLD (14) , DTDST (15) , and sat-1 (16) ; the first two of these genes are defective in congenital chloride diarrhea (17) and diastrophic dysplasia (15) , respectively. Computer modeling predicts that pendrin is a transmembrane glycoprotein containing 11 or 12 transmembrane domains. Using two different expression systems, Xenopus laevis ooctyes and Sf9 insect cells, Scott et al. (18) demonstrated that pendrin can transport iodide and chloride, but not sulfate, in a sodium-independent fashion that is not affected by the anion transporter inhibitor 4,4Ј-diisothiocyanostilbene-2,2Ј-disulfonic acid.
Despite the thyroid pathology seen in Pendred syndrome and the relatively high levels of PDS messenger RNA (mRNA) in this tissue, little is known about the characteristics of pendrin in the thyroid or the regulation of PDS expression. These issues become particularly important in light of the data implicating pendrin with iodide transport (18) . We thus sought to establish the site(s) of pendrin localization in the thyroid as well as to investigate the factors that influence PDS expression. Here we report the initial results of our studies, which include both immunohistochemical analyses using newly developed pendrin-specific antibodies as well as studies of PDS expression in a functioning thyrocyte cell line widely used to study iodide transport (19 -21) . Together, our results strongly suggest an important and central role for pendrin in the thyroid.
Materials and Methods

Generation of pendrin peptide-specific antibodies
Rabbit antipeptide antibodies were raised against the following peptides corresponding to rat or human pendrin (Zymed Laboratories, Inc., South San Francisco, CA): QQQHERRKQERK [amino acids 34 -44 in human pendrin (GenBank AF030880)], PTKEIEIQVDWNSE [amino acids 630 -643 in human pendrin; same sequence in rat pendrin (GenBank AF167412)], and NNAFEPDEDVEEPE (amino acids 612-625 in rat pendrin). The resulting polyclonal antibodies were purified by affinity chromatography with Sepharose CL4B coupled with the synthetic peptide (Zymed Laboratories, Inc.).
Expression of recombinant PDS
The human PDS open reading frame, cloned into the vector pGEMHE (18) , was transferred into the pcDNA3.1-mycHis expression vector (Invitrogen) such that the 3Ј-end of the PDS mRNA was in-frame with the myc epitope and His tag (details available on request). The sequence of the insert in the resulting plasmid (pcDNA3.1-hPDS-mycHis) was determined to verify its integrity.
Cell culture and DNA transfection
All cells were grown at 37 C in a humidified atmosphere with 5% CO 2 . In all cases, the medium was changed every other day, and cells were passaged every 6 -8 days. Human thyroid cancer cell lines used in this study (WRO-82 and NPA-87) were gifts from Dr. Jun Saito (University of Chiba Medical School, Chiba, Japan FRTL-5 (American Type Culture Collection CRL-8305) and FRT rat thyroid cells were used as previously described (22) and were provided by the Interthyr Research Foundation (Baltimore, MD). FRTL-5 cells were diploid and between their 5th and 25th passage. The medium for both was Coon's modified Ham's F-12 supplemented with 5% calf serum (Life Technologies, Inc./BRL, Gaithersburg, MD) and 1 mm nonessential amino acids (Microbiological Associates, Bethesda, MD). The medium for FRTL-5 cells also included a six-hormone mixture (6H medium), containing bovine TSH (1 ϫ 10 Ϫ10 M), insulin (10 g/ml), cortisol (0.4 ng/ml), transferrin (5 g/ml), glycyl-l-histidyl-l-lysine acetate (10 ng/ ml), and somatostatin (10 ng/ml). In some experiments, medium lacking TSH (termed 5H medium) or medium lacking TSH and insulin with 0.2% serum rather than 5% serum (termed 4H medium) was used.
Human embryonic kidney cells (HEK293; American Type Culture Collection CRL-1573) were grown in Eagle's Modified MEM (DMEM; Life Technologies, Inc./BRL) supplemented with 10% FBS and 2 mm glutamine in a humidified atmosphere containing 5% CO 2 at 37 C. Cells were grown to 60 -70% confluence and then transfected using the nonliposomic reagent FuGENE (Roche Molecular Biochemicals, Indianapolis, IN). Cells were harvested by trypsinization 2 days after transfection and homogenized in 50 mm sucrose-10 mm Tris containing COMPLETE cocktail protease inhibitors (Roche Molecular Biochemicals). After centrifugation at 700 ϫ g, the resulting supernatant was centrifuged at 100,000 ϫ g for 1 h. The pellet was then resuspended in the same buffer and analyzed by Western blotting.
Western blotting
Approximately 30 g of protein preparations were separated on premade SDS-denaturing 8% polyacrylamide gels (NOVEX, San Diego, CA) and transferred to Protran nitrocellulose (Schleicher & Schuell, Inc., Keene, NH). Protein transfer was verified by Ponceau S staining of the gel. After overnight blocking in Tris-buffered saline supplemented with 0.1% (vol/vol) polyoxyethylene sorbitan monolaurate (Tween-20; Sigma, St. Louis, MO) and 5% nonfat dry milk, nitrocellulose blots were incubated for 2 h with antipendrin antibodies. After washing in Trisbuffered saline-Tween-20 (0.1%), blots were incubated with donkey antirabbit secondary Ig conjugated to horseradish peroxidase (diluted 1:25,000 in blocking solution; Pierce Chemical Co., Rockford, IL). The binding of primary antibodies was then revealed by enhanced chemiluminescence (Supersignal, Pierce Chemical Co.).
Immunohistochemical detection
Immunohistochemistry was performed essentially as previously described (23, 24) . Briefly, approximately 5-m sections were prepared from formalin-fixed, paraffin-embedded thyroid tissue blocks, deparaffinized, and dehydrated with xylene and graded alcohol. Microwave/ pressure cooker pretreatment (two cycles of 10 min each) was performed in 10 mm citrate buffer (pH 6.0). Nonspecific binding sites were blocked by applying 5% normal goat serum diluted in PBS-Tween-20 (0.05%) and incubated at room temperature for 30 min. Primary antibody (h34 -44) diluted 1:500 in 1% normal goat serum-PBS was added, and slides were incubated for 60 min at room temperature. After three 5-min washes in PBS, sections were incubated with biotinylated swine antirabbit IgG (DAKO Corp., Carpenteria, CA) at a 1:200 dilution. After 1 h, sections were subjected to three 5-min washes in PBS. Peroxidase activity was detected with 3,3Ј-diaminobenzidine solution containing 0.003% H 2 O 2 , washed, slightly counterstained with Gill's formula hematoxylin, dehydrated, and mounted.
Northern blot analysis
Total RNA was prepared using a Total RNA Isolation Kit (5 Prime, 3 Prime, Inc., Boulder City, CO) with minor modifications to the manufacturer's protocol: a 10-cm dish of cultured cells was used and volumes were doubled. Northern analyses, radiolabeling, hybridization, and washing procedures have been described previously (22) . Quantitation of the resulting signal was performed with a BAS-1500 Bioimaging Analyzer (Fuji Photo Film Co., Ltd., Tokyo, Japan). The probe for TG (TG) was described previously (22) . The sodium iodide symporter (NIS) probe was prepared by RT-PCR using FRTL-5 cell polyadenylated RNA and primers 5ЈAAGTTCCTGTGGATGTGCG3Ј and 5ЈTCACACCGTACATGGAGAGC3Ј (yielding a 529-bp fragment) (19, 22) . The glyceraldehyde-3-phosphate dehydrogenase (GAPDH) probe was derived from pTR1-GAPDH-Rat template (Ambion, Inc., Austin, TX) and subcloned into pBluescript SK ϩ (Stratagene, La Jolla, CA). The PDS-specific probe was a mixture of three PCR products that together cover most of the PDS-coding region (GenBank AF030880). These products were generated with the following pairs of primers: 5ЈTGCTGACTTCATTGCTGGGTTAC3Ј and 5ЈAATCCAGAGAAGACGTTGCTTATCC3Ј, 5ЈTACCACTGCTCTG-TCTCGAACGG3Ј and 5ЈGCCATTCCACGAAGGGAACTG3Ј, and 5ЈTGAAGATCCTGAGATTTTCCAGTCC3Ј and 5ЈTGTGGATTGG-CACCTTCGG3Ј.
Results
Development and characterization of antipendrin antibodies
Rabbit polyclonal antibodies were raised to three pendrinspecific synthetic peptides. The latter correspond to domains within the amino-or carboxyl-termini of the predicted protein. Using a recombinant protein consisting of human pendrin fused to a myc epitope and 6ϫHis tag (expressed in HEK293 cells) as a positive control, each of the antibodies was tested by Western blotting. When transiently expressed in HEK293 cells, a 95-to 100-kDa protein was detected with all three antibodies (Fig. 1) ; note that the predicted size of the unmodified fusion protein was approximately 91 kDa. In all cases, incubation with preimmune serum yielded no signal at 95-100 kDa, and preabsorption of the antibody with an excess of the peptide used for immunization abolished the signal (data not shown).
Immunohistochemical analysis of thyroid sections
We used the h34 -44 pendrin-specific antibody to establish the subcellular location of pendrin in human thyroid by immunohistochemical staining. In normal tissue, pendrin staining was variable from follicle to follicle (data not shown), consistent with heterogeneity of follicular function (25) . However, in all cases staining was limited to the apical surface of the follicular epithelium ( Fig. 2A) . Staining was markedly more pronounced with a thyroid specimen obtained from a patient with Graves' disease (Fig. 2B) , with staining encountered in a larger proportion of follicular cells. Higher magnification revealed extensive staining limited to the apical surface, including microvilli and pseudopods (Fig.  2C) . In all studies, preimmune serum yielded no staining. Similarly, preabsorption of the antibody with an excess of the peptide used for immunization eliminated the staining. In similar studies with rat thyroid tissue, the h630 -643 antibody specifically stained the apical membrane of an even more limited set of thyrocytes compared with normal human tissue (data not shown).
Studies of PDS expression
We performed Northern analysis of mRNA derived from a series of rat and human thyroid cell lines. High expression of PDS mRNA was encountered in normally functioning rat FRTL-5 cells (26) and primary cultured human thyroid cells, but not in rat C cells, rat nonfunctioning FRT cells, or various cells lines derived from human thyroid carcinomas (anaplastic, follicular, and papillary; Fig. 3) .
FRTL-5 cells possess many of the functional and growth characteristics of mammalian thyroid follicular cells (27) . As such, this cell line has been used extensively for studying thyroid function, including iodide transport (20, 28) . The expression of PDS in FRTL-5 cells thus provides a model system for examining factors that influence the expression of this gene. The growth and function of FRTL-5 cells are controlled by hormones such as TSH and insulin (29); thyroidspecific gene expression is also regulated by iodide and follicular TG (30) . We treated FRTL-5 cells with various hormones and compounds known to modulate thyroid cell function and analyzed the resulting mRNA by Northern analysis with PDS and other thyroid-specific gene probes. Of the various agents added to the culture medium, only follicular TG significantly increases PDS expression in FRTL-5 cells (Fig. 4A) . Neither BSA nor mannitol had any effect, indicating that the TG action is not a consequence of osmotic changes (Fig. 4B) . Interestingly, TSH and interferon-␥ had no detectable influence on PDS expression, strikingly different from other thyroid-specific genes [e.g. those encoding TG and the sodium iodide symporter (NIS); Fig. 4A ]. Similarly, T 3 , tetraiodothyronine or T 4 , and NaI had no effect, suggesting that it is not an iodinated product derived from TG that stimulates PDS expression (Fig. 4C) . The optimal TG concentration for enhancing PDS expression appears to be approximately 1 mg/ml (Fig. 4B) , well within the physiological range [0.1-3 mg/ml in normal thyroid (31) ]. The effect is less pronounced with higher concentrations (up to about 10 mg/ml). In contrast, the genes encoding NIS and TG are both strongly suppressed by high TG concentrations. Finally, the TG-stimulating effect is detectable after 3 h and is maximal after 24 h (Fig. 4D) .
Discussion
The unusual combination of deafness and goiter encountered in Pendred syndrome raises some interesting questions about how defects in the same protein (pendrin) lead to the distinct and tissue-specific effects. To gain insight about such issues, we are studying PDS expression and pendrin subcellular localization in various tissues. For example, we recently examined the expression of the mouse ortholog (Pds) in the developing inner ear; Pds mRNA was detected in highly discrete, nonsensory regions at specific developmental stages (12) . The latter results, in conjunction with the profound deafness associated with PDS mutations, point to a direct and critical role for pendrin in inner ear development and function.
In the present study, we focused on PDS and pendrin in the thyroid. Using peptide-specific antibodies and immunohistochemical techniques, we demonstrated that pendrin is limited to the apical membrane of human and rat thyrocytes lining the follicular lumen. In normal thyroid tissue, the staining is notably heterogeneous, as is follicular function; in thyroid from a patient with Graves' disease, significantly greater amounts of pendrin were detected in a larger fraction of cells. Thus, pendrin production appears to correlate with   FIG. 4 . Northern blot analysis of FRTL-5 cells under different growth conditions. Purified total mRNA (10 g each) from FRTL-5 cells cultured in the indicated fashion was subjected to Northern analysis, with the resulting blots hybridized with PDS-, NIS-, TG-, or GAPDHspecific probes (as indicated) and subjected to autoradiography. In A, 4H, 5H, or 6H medium was used (see Materials and Methods for details) containing 0.2% or 5% serum. Thus, 4H0.2 corresponds to 4H medium containing 0.2% serum. In lane 3, cells were grown in 4H medium (devoid of TSH and insulin) containing 0.2% serum for 8 days and then exposed to TSH (10 mU/ml) for 48 h, at which time RNA was isolated. In lanes 8 -10, cells were grown in 6H medium containing 5% serum for 8 days and then exposed to methimazole (MMI; 5 mM), TG (1 mg/ml), or interferon-␥ (IFN-␥; 100 U/ml), respectively, for 48 h, at which time RNA was isolated. In B, FRTL-5 cells in 6H medium were incubated in serum-free medium containing 0.1, 1, or 10 mg/ml TG (lanes 2, 3, and 4, respectively); 0.1, 1, or 10 mg/ml BSA (lanes 5, 6, and 7, respectively); and 0.1 or 10 mg/ml mannitol (lanes 8 and 9, respectively), and RNA was extracted 48 h later. In C, FRTL-5 cells in 6H medium were incubated in serum-free medium containing TG (1 mg/ml; lane 2), T 3 (10 Ϫ8 , 10 Ϫ7 , or 10 Ϫ6 M; lanes 3, 4, and 5, respectively), T 4 (10 Ϫ7 , 10
Ϫ6
, or 10 Ϫ5 M; lanes 6, 7, and 8, respectively), and NaI (10 Ϫ4 , 10 Ϫ3 , or 10 Ϫ2 M; lanes 9, 10, and 11, respectively). In D, FRTL-5 cells in 6H medium were incubated in serum-free medium containing 1 mg/ml TG for the indicated periods of time, and then RNA was extracted.
the functional status of the thyroid follicles, at least in the case of Graves' disease; that is, pendrin is produced at higher levels when iodide transport, organification, TG turnover, and thyroid hormone formation are high.
With the biochemical evidence that pendrin transports iodide and chloride (18) and now our immunohistochemical results, it seems plausible to postulate that pendrin functions as an apical porter of iodide in the thyrocyte, serving to transport intracellular iodide into the follicular lumen. In this regard, pendrin may work in partnership with NIS, the classic iodide transporter localized within the basolateral membrane that is responsible for the transfer of iodide from the bloodstream into the thyrocyte. Previous studies have indicated the presence of an apical iodide channel responsible for iodide efflux into the colloid (20, (32) (33) (34) . Such a channel should be TSH regulated (35, 36) and should be highly permeable and specific for iodide, with a K m of 70 m (34, 37). As PDS expression does not appear to be affected by TSH, perhaps pendrin acts as an additional apical porter of iodide. Moreover, other studies (20, 36) have found less specificity for iodide and showed that the TSH-regulated function occurs through a calcium/inositol phosphate/arachadonic acid pathway rather than regulation at the RNA level (38) .
The detection of pendrin in a subset of follicles and in a subset of thyrocytes within individual follicles is consistent with the observation that thyroid follicles are not synchronized (30) . Rather, they are heterogeneous in shape, size, colloid density, iodide uptake, and, as it turns out, production of pendrin. The latter is similar to NIS in the basolateral membrane, which is typically detected in approximately 20% of the thyrocytes (39) . An open question is whether the same or distinct sets of thyrocytes express both pendrin and NIS.
Prompted by the knowledge that pendrin is an apical iodide porter, we initiated studies to examine PDS expression in a system conducive to experimental manipulation. Several cell lines derived from normal and malignant thyroid tissue were analyzed by Northern analysis. Only primary human thyroid cells and rat FRTL-5 cells were found to express significant amounts of PDS mRNA. FRTL-5 is a stable thyroid cell line derived from thyroid glands of Fischer rats under defined culture conditions. This cell line has been widely adopted as a model system for the study of thyroid cell function and for bioassays (27) . The FRT cell line displays no features reminiscent of functional thyroid cells (e.g. lack of iodide uptake or TG synthesis due to the absence of TTF-1). FRT cells were not found to express PDS.
Various growth factors and hormones were tested for their effect on PDS expression in FRTL-5 cells. TSH is the classic hormone known to regulate thyroid function. Whereas TSH enhances NIS expression, it has no effect on PDS expression. Indeed, of the agents tested, only TG was found to markedly increase the levels of PDS mRNA. TG, the major secretory product of the thyroid, is the protein precursor for thyroid hormones. It is a large 330-kDa glycoprotein that undergoes homodimerization in the endoplasmic reticulum and other posttranslational modifications (e.g. phosphorylation, N-and O-glycosylation, sulfation, and iodination) (40) . TG mRNA production is regulated by TSH as well as insulin and insulin-like growth factor I. TSH also stimulates the reabsorption of TG from the colloid. TG becomes a potent feedback regulator of follicular function as its synthesis and secretion into the follicular lumen occurs. It suppresses multiple thyroid-specific transcription factors (e.g. TTF-1, Pax-8, and TTF-2) (22), thereby decreasing the expression of TG, TPO, TSHR, and NIS as well as iodide uptake in the thyroid. This is in contrast to the TG-induced increase in expression of genes encoding class I molecules (22) and pendrin (this study). TG is known to bind the asialoglycoprotein receptor in the apical membrane (41) , although the subsequent intracellular signaling pathway remains to be established. Of note, TG with a low iodide and immature carbohydrate content binds better to the asialoglycoprotein receptor (42, 43) .
One possible explanation for TG-enhanced PDS expression is that pendrin is necessary for ensuring that a sufficient amount of iodide gets into the follicle when a critical amount of TG has accumulated, ready for iodination. In Graves' disease, the thyroid TG concentration is lower than normal (so-called empty follicles). The latter is thought to occur due to an overstimulation of the TSH receptor by autoantibodies, leading to intensive synthesis and reabsorption of TG. We found pendrin to be more abundant in Graves' disease thyroid than in normal thyroid, possibly because the recently synthesized TG binds better to the asialoglycoprotein receptor and enhances the TG signal. Interestingly, NIS is also more abundant in Graves' disease thyroid, but, unlike pendrin, is decreased by TG. Thus, NIS and pendrin appear to be controlled by distinct regulatory mechanisms.
The results obtained with TG-induced stimulation of pendrin production suggest a potential local role for follicular TG in the regulation of iodide metabolism. Genes essential for iodide organification and thyroid hormone biosynthesis (e.g. TG, TPO, and NIS) are constitutively expressed in thyroid cells by the constant stimulation of TSH, unless suppression by follicular TG overcomes the TSH stimulation. In a follicle in which TG levels are low, expression of these genes is maximal. As a result, newly synthesized TG begins to accumulate, and PDS expression, initially low in an almost empty follicle, becomes enhanced. When the TG concentration reaches an even higher level, PDS expression returns to its lower constitutive levels, and NIS expression is suppressed. The synthetic process is ended, but any iodide taken into the cells can be extruded by pendrin into the follicular lumen and coupled to TG.
In summary, we developed antibodies to pendrin and provided the first insight into the subcellular localization of the protein in the thyroid, which points to its likely role as an apical porter of iodide. Characterization of PDS expression in FRTL-5 cells has revealed an expanded role for TG in regulating the biosynthesis of proteins central to iodide transport and thyroid hormone production. Together, these studies contribute to the complex network of proteins involved in the regulation and biosynthesis of thyroid hormones.
